HomeSearchCANCER DRUG RESISTANCE

CANCER DRUG RESISTANCE

OAE PUBLISHING INC · US · Est. 2006

ISSN2578-532XeISSN2578-532X
WOS ESCI
10
/ 100
High Risk
Score Breakdown
WoS ESCI+10
Total10
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
H-Index
38
CiteScore
8.3
SNIP
0.918
Total Works
504
Total Citations
8,701
2yr Mean Citedness
4.93
Free JIF alternative

Aims & Scope

Cancer Drug Resistance aims to publish high-quality original research articles, reviews, and commentaries on all aspects of cancer drug resistance. The journal covers topics such as mechanisms of resistance, biomarkers of resistance, novel therapeutic strategies to overcome resistance, and the role of the tumor microenvironment in drug resistance. We welcome submissions on preclinical and clinical studies, as well as translational research that bridges basic science and clinical application.

General Information

Country / RegionUS
Primary LanguageEnglish
1st Year Published2006
StatusActive (last: 2026)
Total Publications504
OA Since2017
Visit Journal Website

Submission Info

Peer Reviewsingle-blind
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

7/12 · 58%
Do you know the journal / publisher?
OAE PUBLISHING INC
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2578-532X / 2578-532X
Indexed in a trusted database?
N/A
Peer review process documented?
single-blind
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Web of Science Categories

Oncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Cells and MetastasisCancer Genomics and DiagnosticsMicroRNA in disease regulationEpigenetics and DNA MethylationCancer, Hypoxia, and MetabolismCancer therapeutics and mechanismsHistone Deacetylase Inhibitors ResearchCancer-related molecular mechanisms researchHER2/EGFR in Cancer Research
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref